Comparable outcomes with bortezomib-cyclophosphamide-dexamethasone (VCD) and bortezomib-lenalidomide-dexamethasone (VRD) for initial treatment of newly diagnosed multiple myeloma (MM)

 Article Details
Title: Comparable outcomes with bortezomib-cyclophosphamide-dexamethasone (VCD) and bortezomib-lenalidomide-dexamethasone (VRD) for initial treatment of newly diagnosed multiple myeloma (MM)
Dateline: 2013-12-07    DisplayDateline   
Byline: Kumar SK, Engebretson AE, Buadi FK, Lacy MQ, Dispenzieri A, Sheng Duh M, Lafeuille M, Lefebvre P, Cheng W, Dea K, Yap M, Saravanan S, Rembert D, Patt D, Niculescu L, Ba-Mancini A, Ma E, Rajkumar SV
Publication Title: ASH  
CTA Link: https://ashpublications.org/blood/article/122/21/3178/12305/Comparable-Outcomes-With-Bortezomib
CTA Text: Read More
Filter(s):*
This creates the tags that filter the listing page by specific taxonomies that display to the right of the main content and read more link.
 
 

top